BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7941678)

  • 21. [Usefulness of exercise tests in the evaluation of the effects of treatment in chronic cardiac insufficiency].
    Zannad F
    Rev Prat; 1990 Oct; 40(23 Suppl):31-5. PubMed ID: 2267563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial measurements of peripheral vascular reactivity and exercise capacity in congestive heart failure and after heart transplantation.
    Hognestad A; Holm T; Simonsen S; Kjekshus J; Andreassen AK
    J Card Fail; 2005 Aug; 11(6):447-54. PubMed ID: 16105636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug treatment of cardiac insufficiency with systolic dysfunction].
    Follath F
    Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of exercise testing in heart failure.
    Swedberg K; Gundersen T
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S13-7. PubMed ID: 7514235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peripheral circulatory and metabolic changes in cardiac insufficiency. Therapeutic implications].
    Duboc D; Guérin F
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1949-51. PubMed ID: 2125414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise testing and training in patients with chronic heart failure.
    Hanson P
    Med Sci Sports Exerc; 1994 May; 26(5):527-37. PubMed ID: 8007798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
    Guazzi M; Pontone G; Trevisi N; Lomanto M; Melzi G; Agostoni P
    Ann Ital Med Int; 1998; 13(1):17-23. PubMed ID: 9642838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
    Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Muscle changes and exercise intolerance in congestive heart failure: main role of the periphery].
    Cicoira M
    Ital Heart J Suppl; 2002 Sep; 3(9):908-12. PubMed ID: 12407858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Physical training of patients with high grade compromise of heart pumping function].
    Schuler G; Hambrecht R
    Z Kardiol; 1996; 85 Suppl 6():253-61. PubMed ID: 9064974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial.
    Erbs S; Linke A; Gielen S; Fiehn E; Walther C; Yu J; Adams V; Schuler G; Hambrecht R
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):336-44. PubMed ID: 14663295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How does cardiac resynchronization therapy improve exercise capacity in chronic heart failure?
    Middlekauff HR
    J Card Fail; 2005 Sep; 11(7):534-41. PubMed ID: 16198250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacotherapy of acute heart failure: update and perspectives].
    Link A; Pöss J; Böhm M
    Dtsch Med Wochenschr; 2012 May; 137(21):1126-9. PubMed ID: 22588659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal muscle blood flow, metabolism and morphology in chronic congestive heart failure and effects of short- and long-term angiotensin-converting enzyme inhibition.
    Drexler H; Hiroi M; Riede U; Banhardt U; Meinertz T; Just H
    Am J Cardiol; 1988 Sep; 62(8):82E-85E. PubMed ID: 3046293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.